Of importance, we reported in NPM-ALK+ ALCL that such combined ALK and mTOR inhibition, using crizotinib and rapamycine, respectively, resulted in an increased autophagic flux and loss of cell viability [17]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.